Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Novel therapeutic agents in clinical development for systemic lupus erythematosus

BMC Medicine201311:120

DOI: 10.1186/1741-7015-11-120

Received: 31 October 2012

Accepted: 9 April 2013

Published: 3 May 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Oct 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Dec 2012 Reviewed Reviewer Report - George Bertsias
8 Jan 2013 Reviewed Reviewer Report - Nora Singer
Resubmission - Version 3
Submitted Manuscript version 3
21 Mar 2013 Author responded Author comments - Claire Barnard
Resubmission - Version 4
21 Mar 2013 Submitted Manuscript version 4
26 Mar 2013 Reviewed Reviewer Report - George Bertsias
Resubmission - Version 5
Submitted Manuscript version 5
28 Mar 2013 Author responded Author comments - Claire Barnard
Resubmission - Version 6
28 Mar 2013 Submitted Manuscript version 6
Publishing
9 Apr 2013 Editorially accepted
3 May 2013 Article published 10.1186/1741-7015-11-120

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Louise Coote Lupus Unit, St Thomas’ Hospital

Advertisement